Back to Insider Trading View Full Company Profile

AORT

HEALTHY

ARTIVION, INC.

CIK: 0000784199

Strong Sell (90% confidence)

Last activity: Mar 4, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Net Income -$2.84M
Total Cash $64.91M
Current Ratio 1.04

Insider Roster (6 total, 6 active)

Insider Buys Sells Net Value Holdings
Mackin James P
President & CEO
0 4 -$2.53M
947,275 shares
$35.78M
Berry Lance A
EVP, COO, CFO & Treasurer
0 4 -$783K
210,827 shares
$7.96M
Holloway Jean F
SVP, General Counsel
0 5 -$744K
185,095 shares
$7.03M
Davis John E
Chief Commercial Officer
0 5 -$720K
230,794 shares
$8.72M
Horton Amy
VP, Chief Accounting Officer
0 5 -$356K
139,088 shares
$5.25M
Stanton Marshall S.
SVP, Clinical & MD Affair
0 4 -$275K
60,097 shares
$2.27M

Recent Transactions

SELL Holloway Jean F (SVP, General Counsel)

8,962 shares @ $38.00

$341K

Mar 4, 2026

Conviction: | View SEC Filing →
SELL Mackin James P (President & CEO)

17,887 shares @ $37.78

$676K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL Berry Lance A (EVP, COO, CFO & Treasurer)

6,316 shares @ $37.78

$239K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL Davis John E (Chief Commercial Officer)

4,573 shares @ $37.78

$173K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL Holloway Jean F (SVP, General Counsel)

3,843 shares @ $37.78

$145K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL Stanton Marshall S. (SVP, Clinical & MD Affair)

2,149 shares @ $37.78

$81K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL Horton Amy (VP, Chief Accounting Officer)

901 shares @ $37.78

$34K

Mar 3, 2026

Conviction: | View SEC Filing →
SELL Mackin James P (President & CEO)

14,911 shares @ $38.02

$567K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Berry Lance A (EVP, COO, CFO & Treasurer)

5,178 shares @ $38.02

$197K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Davis John E (Chief Commercial Officer)

2,784 shares @ $38.02

$106K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Holloway Jean F (SVP, General Counsel)

2,183 shares @ $38.02

$83K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Stanton Marshall S. (SVP, Clinical & MD Affair)

1,513 shares @ $38.02

$58K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Horton Amy (VP, Chief Accounting Officer)

641 shares @ $38.02

$24K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Mackin James P (President & CEO)

13,936 shares @ $35.69

$497K

Feb 24, 2026

Conviction: | View SEC Filing →
SELL Berry Lance A (EVP, COO, CFO & Treasurer)

4,485 shares @ $35.69

$160K

Feb 24, 2026

Conviction: | View SEC Filing →
SELL Davis John E (Chief Commercial Officer)

2,075 shares @ $35.69

$74K

Feb 24, 2026

Conviction: | View SEC Filing →
SELL Holloway Jean F (SVP, General Counsel)

1,668 shares @ $35.69

$60K

Feb 24, 2026

Conviction: | View SEC Filing →
SELL Stanton Marshall S. (SVP, Clinical & MD Affair)

1,259 shares @ $35.69

$45K

Feb 24, 2026

Conviction: | View SEC Filing →
SELL Horton Amy (VP, Chief Accounting Officer)

830 shares @ $35.69

$30K

Feb 24, 2026

Conviction: | View SEC Filing →
SELL Mackin James P (President & CEO)

20,962 shares @ $37.59

$788K

Feb 23, 2026

Conviction: | View SEC Filing →
SELL Berry Lance A (EVP, COO, CFO & Treasurer)

4,981 shares @ $37.59

$187K

Feb 23, 2026

Conviction: | View SEC Filing →
SELL Davis John E (Chief Commercial Officer)

3,773 shares @ $37.59

$142K

Feb 23, 2026

Conviction: | View SEC Filing →
SELL Holloway Jean F (SVP, General Counsel)

3,079 shares @ $37.59

$116K

Feb 23, 2026

Conviction: | View SEC Filing →
SELL Stanton Marshall S. (SVP, Clinical & MD Affair)

2,423 shares @ $37.59

$91K

Feb 23, 2026

Conviction: | View SEC Filing →
SELL Horton Amy (VP, Chief Accounting Officer)

1,731 shares @ $37.59

$65K

Feb 23, 2026

Conviction: | View SEC Filing →
SELL Davis John E (Chief Commercial Officer)

5,000 shares @ $45.11

$226K

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Horton Amy (VP, Chief Accounting Officer)

4,572 shares @ $44.42

$203K

Dec 8, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.